Clinical Trial Update: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and immunogenicity of VEE C-84 as a booster to VEE TC-83.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venezuelan Equine Encephalitis

Drugs mentioned

• VEE C-84
• VEE TC-83

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Venezuelan Equine Encephalomyelitis | Phase 2 | Status: UNKNOWN